These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 2443619

  • 1. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
    Petrelli N, Herrera L, Rustum Y, Burke P, Creaven P, Stulc J, Emrich LJ, Mittelman A.
    J Clin Oncol; 1987 Oct; 5(10):1559-65. PubMed ID: 2443619
    [Abstract] [Full Text] [Related]

  • 2. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
    Poon MA, O'Connell MJ, Moertel CG, Wieand HS, Cullinan SA, Everson LK, Krook JE, Mailliard JA, Laurie JA, Tschetter LK.
    J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
    [Abstract] [Full Text] [Related]

  • 3. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group.
    Valone FH, Friedman MA, Wittlinger PS, Drakes T, Eisenberg PD, Malec M, Hannigan JF, Brown BW.
    J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272
    [Abstract] [Full Text] [Related]

  • 4. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ, Madajewicz S, Herrera L, Rustum YM, Trave F, Creaven P, Mittelman A.
    NCI Monogr; 1987 Oct; (5):189-92. PubMed ID: 3501541
    [Abstract] [Full Text] [Related]

  • 5. Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
    Abad A, Garcia P, Gravalos C, Tusquets I, Font A, Perez G, Cortés-Funes H, Fabregat X, Barnadas A, Rosell R.
    Cancer; 1995 Mar 15; 75(6):1238-44. PubMed ID: 7882275
    [Abstract] [Full Text] [Related]

  • 6. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Pérez JE, Rodríguez R, Cuevas MA, Alvarez LA.
    Am J Clin Oncol; 1991 Jun 15; 14(3):211-7. PubMed ID: 2031508
    [Abstract] [Full Text] [Related]

  • 7. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T, Futatsuki K, Akazawa S, Yamamoto K, Miyazaki M, Kanda Y, Amemiya K, Uchida N, Oishi T.
    Gan To Kagaku Ryoho; 1993 Apr 15; 20(5):603-9. PubMed ID: 8470917
    [Abstract] [Full Text] [Related]

  • 8. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D, Goldschmidt E, Chollet P, Metzger G, Zittoun J, Marquet J, Vandenbulcke JM, Misset JL, Schwarzenberg L, Fourtillan JB.
    J Clin Oncol; 1986 May 15; 4(5):685-96. PubMed ID: 3517242
    [Abstract] [Full Text] [Related]

  • 9. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A.
    J Clin Oncol; 1996 Aug 15; 14(8):2274-9. PubMed ID: 8708717
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer.
    Scheithauer W, Depisch D, Kornek G, Pidlich J, Rosen H, Karall M, Prochaska M, Ernst A, Sebesta C, Eckhardt S.
    Cancer; 1994 Mar 15; 73(6):1562-8. PubMed ID: 8156482
    [Abstract] [Full Text] [Related]

  • 11. Continuous 5-fluorouracil infusion and pulse methotrexate/leucovorin for colorectal adenocarcinoma. A report of excessive toxicity.
    Hansen RM, Quebbeman EJ, Ritch PS, Frick J, Anderson T.
    Am J Clin Oncol; 1987 Jun 15; 10(3):216-8. PubMed ID: 3496002
    [Abstract] [Full Text] [Related]

  • 12. Sequential methotrexate, 5-fluorouracil, and calcium leucovorin in colorectal carcinoma.
    Hansen RM, Ritch PS, Anderson T.
    Am J Clin Oncol; 1986 Aug 15; 9(4):352-4. PubMed ID: 3489407
    [Abstract] [Full Text] [Related]

  • 13. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
    Pronzato P, Vaira F, Vigani A, Losardo P, Bertelli G.
    Anticancer Res; 1995 Aug 15; 15(6B):2679-82. PubMed ID: 8669846
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.
    Grem JL, McAtee N, Balis F, Murphy R, Venzon D, Kramer B, Goldspiel B, Begley M, Allegra CJ.
    Cancer; 1993 Aug 01; 72(3):663-8. PubMed ID: 8334622
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
    Erlichman C, Fine S, Wong A, Elhakim T.
    J Clin Oncol; 1988 Mar 01; 6(3):469-75. PubMed ID: 3280741
    [Abstract] [Full Text] [Related]

  • 16. Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study.
    Hines JD, Zakem MH, Adelstein DJ, Rustum YM.
    J Clin Oncol; 1988 Jan 01; 6(1):142-6. PubMed ID: 3257256
    [Abstract] [Full Text] [Related]

  • 17. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    Köhne CH, Wils J, Lorenz M, Schöffski P, Voigtmann R, Bokemeyer C, Lutz M, Kleeberg C, Ridwelski K, Souchon R, El-Serafi M, Weiss U, Burkhard O, Rückle H, Lichnitser M, Langenbuch T, Scheithauer W, Baron B, Couvreur ML, Schmoll HJ, European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    J Clin Oncol; 2003 Oct 15; 21(20):3721-8. PubMed ID: 12963704
    [Abstract] [Full Text] [Related]

  • 18. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.
    Petrelli N, Douglass HO, Herrera L, Russell D, Stablein DM, Bruckner HW, Mayer RJ, Schinella R, Green MD, Muggia FM.
    J Clin Oncol; 1989 Oct 15; 7(10):1419-26. PubMed ID: 2674331
    [Abstract] [Full Text] [Related]

  • 19. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Oct 15; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 20. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A, Tsavaris N, Giannopoulos A, Bacoyiannis C, Papadimas V, Kalahanis N, Karatzas G, Kosmas C, Sakelaropoulos N, Archimandritis A, Papachristodoulou A, Kosmidis P.
    Cancer Chemother Pharmacol; 1996 Oct 15; 38(3):292-7. PubMed ID: 8646806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.